ATCC Awarded 10-year US Department of Defense Joint Program Executive Office Chemical and Biological Defense JE-RDAP Contract
Providing the DoD with premier biological materials and services
Manassas, VA, United StatesApril 06, 2018
ATCC, a global leader in biological materials development, management and standards, today announced it has been awarded a 10-year contract through the U.S. Department of Defense’s (DoD) Joint Enterprise-Research, Development, Acquisition, and Production/Procurement (JE-RDAP), an omnibus Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle to attain future research, development, acquisition, procurement and fielding of CBRNE defense systems, equipment and materiel.
ATCC is recognized for its biological materials manufacturing, production, storage and global distribution capabilities under an ISO-certified Quality Management System and has supported the federal government for over 50 years with biological products and innovative solutions — highlighted by ATCC’s commitment to quality and responsive management.
“ATCC is proud to be awarded this contract as it allows us to expand our support to the federal government and help protect our nation from current and future biological threats”, said Dr. Joseph Leonelli, vice president for ATCC’s Microbiology and Government Solutions business.
“ATCC looks forward to providing JPEO-CBD with the premier biological defense materials and services for which our company is well known”.
The JE-RDAP contracting strategy aligns with JPEO-CBD’s firm commitment to reduce the time required to award future task orders and deliver innovative solutions.
ATCC is a premier global biological materials and information resource and standards organization and the leading developer and supplier of authenticated cell lines, microorganisms, and associated data for academia, industry, and government. With a history of scientific contributions spanning nearly a century, ATCC offers an unmatched combination of being the world’s largest and most diverse collection of biological reference materials and data, and is a mission-driven, trusted partner that supports and encourages scientific collaboration. ATCC products, services, partnerships, and people provide the global scientific community with credible, advanced, model systems to support complex research and innovations in basic science, drug discovery, translational medicine, and public health. ATCC is a 501(c)3 nonprofit organization with headquarters in Manassas, Virginia, and a research and technology center of excellence in Gaithersburg, Maryland.
Contact: Kim Testa, senior director, Corporate Communications & Public Affairs, ATCC, [email protected]